高级检索
杨友玲, 夏彬. 丁苯酞序贯治疗对进展性缺血性脑卒中的效果[J]. 实用临床医药杂志, 2021, 25(3): 19-22. DOI: 10.7619/jcmp.20201403
引用本文: 杨友玲, 夏彬. 丁苯酞序贯治疗对进展性缺血性脑卒中的效果[J]. 实用临床医药杂志, 2021, 25(3): 19-22. DOI: 10.7619/jcmp.20201403
shu
YANG Youlin, XIA Bin. Effect of sequential treatment of progressive ischemic stroke by butylphthalide[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 19-22. DOI: 10.7619/jcmp.20201403
Citation: YANG Youlin, XIA Bin. Effect of sequential treatment of progressive ischemic stroke by butylphthalide[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 19-22. DOI: 10.7619/jcmp.20201403
shu

丁苯酞序贯治疗对进展性缺血性脑卒中的效果

Effect of sequential treatment of progressive ischemic stroke by butylphthalide

    摘要
  • 摘要:
      目的  观察丁苯酞序贯治疗进展性缺血性脑卒中(PIS)的效果。
      方法  将102例PIS患者随机分为对照组与观察组，每组51例。对照组给予基础治疗，观察组给予丁苯酞序贯治疗联合基础治疗。比较2组治疗前后神经功能缺损评分量表(NIHSS)、日常生活能力(ADL)及血浆巯基丙酮酸硫基转移酶(3-MST)、β淀粉样蛋白42(Aβ42)表达水平和不良反应发生情况。
      结果  2组NIHSS评分均低于治疗前，且观察组低于对照组，差异有统计学意义(P < 0.05)。2组ADL评分均高于治疗前，且观察组高于对照组，差异有统计学意义(P < 0.05)。观察组血浆3-MST水平高于对照组，血浆Aβ42水平低于对照组，差异有统计学意义(P < 0.05)。
      结论  丁苯酞序贯治疗可显著改善PIS患者的神经功能障碍，提高其日常生活能力，安全性良好。

     

    Abstract:
      Objective  To observe the effect of sequential butylphthalide therapy on progressive ischemic stroke (PIS).
      Methods  A total of 102 patients with PIS were randomly divided into control group and observation group, with 51 patients in each group. The control group was given basic treatment, and the observation group was given sequential butylphthalide treatment combined with basic treatment. Neurological deficit score (NIHSS), ability of daily living (ADL), plasma 3-mercaptopyruvate sulfurtransferase (3-MST) and β-amyloid peptide 42 (Aβ42) expression levels as well as the incidence of ADR were compared between two groups before and after treatment.
      Results  The NIHSS scores in two groups were significantly lower than before treatment, and observation group was significantly lower than that in the control group (P < 0.05). The ADL scores in two groups were significantly higher than before treatment, and observation group was significantly higher than that in the control group (P < 0.05). The plasma 3-MST level of observation group was significantly higher than that in the control group, and the plasma Aβ42 level of observation group was significantly lower than that in the control group (P < 0.05).
      Conclusion  Sequential treatment with butylphthalide can significantly improve the neurological dysfunction of patients with PIS, improve the ability of daily living, and has good safety.

     

    • HTML全文
    • 参考文献(26)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回